Actively Recruiting
Bronchial Blockers vs Double-Lumen Tubes in Obese Patients
Led by Paulo Andrés Cano Jiménez · Updated on 2025-06-22
46
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.
CONDITIONS
Official Title
Bronchial Blockers vs Double-Lumen Tubes in Obese Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- BMI ≥ 30 kg/m2
- Diagnostic or clinical suspicion of lung cancer
- Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy requiring one-lung ventilation
- Use of bronchial blocker or double-lumen tube for one-lung ventilation
You will not qualify if you...
- Patients with evident anatomic alterations contraindicating double-lumen tubes
- Emergency surgeries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Son Espases
Palma de Mallorca, Balearic Islands, Spain, 07120
Actively Recruiting
Research Team
P
Paulo Andrés Cano, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here